1. Home
  2. NMG vs LYEL Comparison

NMG vs LYEL Comparison

Compare NMG & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMG
  • LYEL
  • Stock Information
  • Founded
  • NMG 2011
  • LYEL 2018
  • Country
  • NMG Canada
  • LYEL United States
  • Employees
  • NMG N/A
  • LYEL N/A
  • Industry
  • NMG Other Metals and Minerals
  • LYEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NMG Basic Materials
  • LYEL Health Care
  • Exchange
  • NMG Nasdaq
  • LYEL Nasdaq
  • Market Cap
  • NMG 249.7M
  • LYEL 207.7M
  • IPO Year
  • NMG 2017
  • LYEL 2021
  • Fundamental
  • Price
  • NMG $1.94
  • LYEL $10.98
  • Analyst Decision
  • NMG Strong Buy
  • LYEL Sell
  • Analyst Count
  • NMG 2
  • LYEL 2
  • Target Price
  • NMG $2.58
  • LYEL $15.00
  • AVG Volume (30 Days)
  • NMG 185.0K
  • LYEL 68.2K
  • Earning Date
  • NMG 08-18-2025
  • LYEL 08-19-2025
  • Dividend Yield
  • NMG N/A
  • LYEL N/A
  • EPS Growth
  • NMG N/A
  • LYEL N/A
  • EPS
  • NMG N/A
  • LYEL N/A
  • Revenue
  • NMG N/A
  • LYEL $65,000.00
  • Revenue This Year
  • NMG N/A
  • LYEL N/A
  • Revenue Next Year
  • NMG N/A
  • LYEL N/A
  • P/E Ratio
  • NMG N/A
  • LYEL N/A
  • Revenue Growth
  • NMG N/A
  • LYEL N/A
  • 52 Week Low
  • NMG $1.22
  • LYEL $7.65
  • 52 Week High
  • NMG $2.58
  • LYEL $32.40
  • Technical
  • Relative Strength Index (RSI)
  • NMG 53.58
  • LYEL 51.23
  • Support Level
  • NMG $1.89
  • LYEL $10.94
  • Resistance Level
  • NMG $2.00
  • LYEL $12.08
  • Average True Range (ATR)
  • NMG 0.11
  • LYEL 1.03
  • MACD
  • NMG -0.01
  • LYEL -0.09
  • Stochastic Oscillator
  • NMG 40.20
  • LYEL 30.72

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: